Arrowhead Research: Fiscal Q3 Earnings Snapshot
Arrowhead Research: Fiscal Q2 Earnings Snapshot
Arrowhead Research: Fiscal Q1 Earnings Snapshot
Arrowhead Research: Fiscal Q3 Earnings Snapshot
Arrowhead Research: Fiscal Q2 Earnings Snapshot
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal second quarter ended March 31, 2023. The company is hosting a conference call today, May 2, 2023, at 4:30...
Stocks that traded heavily or had substantial price changes Tuesday: UPS, Packaging Corp. fall, Arrowhead, Tenet rise
The clinical-stage biotech announced promising news regarding a potential therapy for inflammatory pulmonary diseases.
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced interim results from an ongoing Phase 1/2 clinical study of ARO-RAGE, the company’s investigational RNA interference (RNAi) therapeutic designed...
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on May 2, 2023, at 4:30 p.m. ET to discuss its financial results for the fiscal 2023 second...